Over the last 7 days, the Biotech industry has dropped 5.9%, driven by a pullback from Swedish Orphan Biovitrum of 4.2%. On the other hand Isofol Medical is actually up 37%. Over the past 12 months, the industry was up 13%. Earnings are forecast to grow by 47% annually.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 06 Aug 2024 | SEK 186.1b | SEK 31.4b | -SEK 5,420,584,602.86 | 41.8x | -34.3x | 5.9x |
Thu, 04 Jul 2024 | SEK 191.7b | SEK 30.6b | -SEK 5,537,333,555.67 | 38.4x | -34.6x | 6.3x |
Sat, 01 Jun 2024 | SEK 198.4b | SEK 30.6b | -SEK 5,725,690,180.58 | 39.8x | -34.7x | 6.5x |
Mon, 29 Apr 2024 | SEK 183.9b | SEK 30.8b | -SEK 5,612,153,350.26 | 50.9x | -32.8x | 6x |
Wed, 27 Mar 2024 | SEK 185.9b | SEK 29.8b | -SEK 5,637,426,016.82 | 61.5x | -33x | 6.2x |
Fri, 23 Feb 2024 | SEK 182.1b | SEK 29.7b | -SEK 5,686,647,248.71 | 52.7x | -32x | 6.1x |
Sun, 21 Jan 2024 | SEK 186.9b | SEK 28.7b | -SEK 1,200,602,862.00 | 57.4x | -155.6x | 6.5x |
Tue, 19 Dec 2023 | SEK 180.9b | SEK 28.7b | -SEK 1,169,941,500.00 | 59.7x | -154.7x | 6.3x |
Thu, 16 Nov 2023 | SEK 166.4b | SEK 28.7b | -SEK 1,230,832,373.00 | 51.2x | -135.2x | 5.8x |
Sat, 14 Oct 2023 | SEK 154.5b | SEK 27.4b | -SEK 1,962,955,624.00 | 48.8x | -78.7x | 5.6x |
Mon, 11 Sep 2023 | SEK 150.4b | SEK 27.4b | -SEK 1,977,547,540.00 | 47x | -76.1x | 5.5x |
Wed, 09 Aug 2023 | SEK 155.6b | SEK 27.5b | -SEK 1,576,205,416.00 | 53.3x | -98.7x | 5.6x |
Fri, 07 Jul 2023 | SEK 160.4b | SEK 26.4b | -SEK 1,278,793,132.00 | 46.6x | -125.4x | 6.1x |
Sun, 04 Jun 2023 | SEK 168.1b | SEK 26.4b | -SEK 1,242,510,092.00 | 45.5x | -135.3x | 6.4x |
Tue, 02 May 2023 | SEK 175.9b | SEK 26.3b | -SEK 1,248,453,450.00 | 45.6x | -140.9x | 6.7x |
Thu, 30 Mar 2023 | SEK 166.5b | SEK 25.4b | -SEK 2,016,640,714.00 | 38.4x | -82.6x | 6.6x |
Sat, 25 Feb 2023 | SEK 170.0b | SEK 25.4b | -SEK 2,041,715,401.00 | 39.6x | -83.3x | 6.7x |
Mon, 23 Jan 2023 | SEK 176.8b | SEK 23.8b | -SEK 1,839,311,016.00 | 32.2x | -96.1x | 7.4x |
Wed, 21 Dec 2022 | SEK 159.1b | SEK 23.8b | -SEK 1,839,194,697.00 | 31.8x | -86.5x | 6.7x |
Fri, 18 Nov 2022 | SEK 157.2b | SEK 23.9b | -SEK 1,807,539,360.00 | 32.4x | -87x | 6.6x |
Sun, 16 Oct 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,333,771,163.00 | 31.2x | -45.9x | 6.7x |
Tue, 13 Sep 2022 | SEK 158.7b | SEK 22.9b | -SEK 3,245,854,870.00 | 33.9x | -48.9x | 6.9x |
Thu, 11 Aug 2022 | SEK 171.2b | SEK 22.7b | -SEK 3,505,517,539.00 | 34.9x | -48.8x | 7.5x |
Sat, 09 Jul 2022 | SEK 164.2b | SEK 21.4b | -SEK 3,520,210,178.00 | 40.3x | -46.7x | 7.7x |
Mon, 06 Jun 2022 | SEK 158.7b | SEK 21.4b | -SEK 3,525,318,201.00 | 44.4x | -45x | 7.4x |
Wed, 04 May 2022 | SEK 150.6b | SEK 21.3b | -SEK 3,496,052,570.00 | 45.9x | -43.1x | 7.1x |
Fri, 01 Apr 2022 | SEK 172.2b | SEK 19.7b | -SEK 3,159,874,686.00 | 51x | -54.5x | 8.7x |
Sun, 27 Feb 2022 | SEK 159.5b | SEK 19.6b | -SEK 2,877,018,904.00 | 49.6x | -55.4x | 8.1x |
Tue, 25 Jan 2022 | SEK 160.7b | SEK 19.1b | -SEK 2,042,162,885.00 | 48.2x | -78.7x | 8.4x |
Thu, 23 Dec 2021 | SEK 198.1b | SEK 19.1b | -SEK 2,003,682,605.00 | 53x | -98.9x | 10.4x |
Sat, 20 Nov 2021 | SEK 202.8b | SEK 19.0b | -SEK 1,412,764,251.00 | 55x | -143.5x | 10.7x |
Mon, 18 Oct 2021 | SEK 200.0b | SEK 18.1b | -SEK 1,345,754,716.00 | 47.3x | -148.7x | 11.1x |
Wed, 15 Sep 2021 | SEK 215.7b | SEK 18.1b | -SEK 1,339,275,285.95 | 53.4x | -161x | 11.9x |
Fri, 13 Aug 2021 | SEK 193.4b | SEK 18.1b | -SEK 1,175,418,285.95 | 53.6x | -164.5x | 10.7x |
-164.5x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -6.69% | |
Healthcare | -6.08% | |
Biotech | -5.91% | |
Biotech | -5.91% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ISOFOL Isofol Medical | SEK 2.67 | 18.7% +SEK 67.8m | 314.6% | PB3.8x | |
ALZ Alzinova | SEK 3.64 | 18.2% +SEK 24.9m | 7.1% | PS9x | |
BIOSGN Biosergen | SEK 0.65 | 13.3% +SEK 10.8m | -29.8% | PB4.3x | |
MODTX Modus Therapeutics Holding | SEK 1.82 | 9.6% +SEK 5.8m | -20.2% | PB4.5x | |
LIPUM Lipum | SEK 11.30 | 1.8% +SEK 4.2m | 23.4% | PS4522.7x |